Thursday, July 02, 2009 | Register | Login |   Search      
 

AvivoClin’s custom, state-of-the-art clinical pharmacology research unit brings together an impressive blend of experience and services. AvivoClin’s management has performed a broad spectrum of clinical studies across virtually every therapeutic area. Working with local hospitals and organizations, we offer customized solutions for our clients’ early phase clinical research needs. We specialize in Phase I-III clinical trials, microdosing, first-in-human safety and tolerance, human mass balance, bioequivalence, PK, cardiac safety, efficacy and label claim studies. AvivoClin also provides comprehensive clinical management services such as clinical monitoring, data management, statistical analyses and regulatory filing support.

 

 
Press Releases

November 11, 2008

Azopharma Unveils New UK Laboratory and EU plans

 
HOLLYWOOD, Fla. – Azopharma Product Development GroupTM is pleased to announce its entrance into the European market with the addition of new laboratory facilities and office space located in Welwyn Garden City, UK. The new facility will provide analytical, QP release testing, preformulation and formulation development services to the European market.
 
Mr. Phil Meeks, CEO of Azopharma Product Development Group says, “This is a very exciting time for Azopharma with our first venture outside the USA. Our vision for the new laboratory is to provide key product development services to our many clients in Europe. We see this facility as the first step in bringing our complete service offerings to the region.”  Read More

 

 

 

Trade Shows

 

Pittcon, Chicago
March 9-12

Tox Expo, Baltimore 
March 15-18

DCAT, New York City
March 16-20

Interphex, New York City
March 17-19

DIA Europe, Berlin 
March 23-25





Copyright 2009 AvivoClin Inc.   Terms Of Use   Privacy Statement   Site Map